FAR Biotech was founded by Dr. Martin Martinov in 2016 after more than two decades in academia and industry refining and applying the computational modeling of quantum mechanical interactions.
We named our company after the Bulgarian word “far” for “lighthouse” or “beacon”, since FAR seeks to shine a light on drug discovery in areas of high unmet clinical need. We explore search spaces that other approaches would not investigate — to identify novel chemical structures against high impact targets.
oGet in touch
Decades of experience and expertise in computational and clinical drug discovery.
Our human capital spans computational drug discovery; preclinical and clinical drug advancement; and deep industry knowledge and relationships.
We have collectively more than 350 peer-reviewed publications in high profile journals around the world.
Martin Martinov PhD
Founder, CEO & Board
Lyubomir Nashev PhD
Research Director
Ravi Nargund PhD
Senior Chemistry Advisor
Eric Parker PhD
Senior Biology Advisor
Senior Advisor
Eugene Cordes PhD
Advisor
Evelyn Nordin MBA
CFO
Max Duckworth
Board & Co-founder